trond aasen
Vall d'Hebron Research Institute (VHIR)
Barcelona, Spain
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
vaishali aggarwal
Department of Immunology, School of Medicine, University of Pittsburgh
Pittsburgh, United States
Review Editor
Cancer Molecular Targets and Therapeutics
massimiliano agostini
University of Rome Tor Vergata
Roma, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
vajihe akbari
Isfahan University of Medical Sciences
Isfahan, Iran
Review Editor
Cancer Molecular Targets and Therapeutics
özlem akgül
Ege University
Bornova, Türkiye
Review Editor
Cancer Molecular Targets and Therapeutics
suleyman akocak
Adiyaman University
Adıyaman, Türkiye
Review Editor
Cancer Molecular Targets and Therapeutics
ayad a. al-hamashi
University of Baghdad
Baghdad, Iraq
Review Editor
Cancer Molecular Targets and Therapeutics
david a. alagpulinsa, phd
School of Medicine, Yale University
New Haven, United States
Review Editor
Cancer Molecular Targets and Therapeutics
manzar alam
University of Texas Southwestern Medical Center
Dallas, United States
Review Editor
Cancer Molecular Targets and Therapeutics
kinan alhallak
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
azhar ali
Cancer Science Institute of Singapore, National University of Singapore
Singapore, Singapore
Review Editor
Cancer Molecular Targets and Therapeutics
chiara ambrogio
University of Turin
Turin, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
maria rosaria ambrosio
Institute for Endocrinology and Experimental Oncology Gaetano Salvatore, Department of Biomedical Sciences, National Research Council (CNR)
Naples, Italy
Review Editor
Cancer Molecular Targets and Therapeutics
ali amin
Rhode Island Hospital
Providence, United States
Review Editor
Cancer Molecular Targets and Therapeutics
jay anand
University of North Carolina at Chapel Hill
Chapel Hill, United States
Review Editor
Cancer Molecular Targets and Therapeutics
simone anfossi
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Molecular Targets and Therapeutics